EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An In Vitro Study on the Application of Silver-Doped Platelet-Rich Plasma in the Prevention of Post-Implant-Associated Infections

Chiara Ceresa iD, Fabio Travagin iD, Alice Marchetti iD, Francesco Tessarolo iD, Letizia Fracchia iD, Giovanni Battista Giovenzana iD, Michela Bosetti iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Chiara Ceresa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Università del Piemonte Orientale "A. Avogadro", 28100 Novara, Italy. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Biofilms, Silver, Osteoblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università del Piemonte Orientale Amedeo Avogadro, Università del Piemonte Orientale, European Union—Fondo Sociale Europeo Recovery Assistance for Cohesion.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Implant therapy is a common treatment option in dentistry and orthopedics, but its application is often associated with an increased risk of microbial contamination of the implant surfaces that cause bone tissue impairment. This study aims to develop two silver-enriched platelet-rich plasma (PRP) multifunctional scaffolds active at the same time in preventing implant-associated infections and stimulating bone regeneration. Commercial silver lactate (L) and newly synthesized silver deoxycholate:β-Cyclodextrin (B), were studied in vitro. Initially, the antimicrobial activity of the two silver soluble forms and the PRP enriched with the two silver forms has been studied on microbial planktonic cells. At the same time, the biocompatibility of silver-enriched PRPs has been assessed by an MTT test on human primary osteoblasts (hOBs). Afterwards, an investigation was conducted to evaluate the activity of selected concentrations and forms of silver-enriched PRPs in inhibiting microbial biofilm formation and stimulating hOB differentiation. PRP-L (0.3 µg/mm2) and PRP-B (0.2 µg/mm2) counteract Staphylococcus aureus, Staphylococcus epidermidis and Candida albicans planktonic cell growth and biofilm formation, preserving hOB viability without interfering with their differentiation capability. Overall, the results obtained suggest that L- and B-enriched PRPs represent a promising preventive strategy against biofilm-related implant infections and demonstrate a new silver formulation that, together with increasing fibrin binding protecting silver in truncated cone-shaped cyclic oligosaccharides, achieved comparable inhibitory results on prokaryotic cells at a lower concentration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich PlasmaBiofilmsSilverOsteoblastsHumansStaphylococcus aureusCandida albicansProsthesis-Related InfectionsStaphylococcus epidermidis

Stichwörter der Autor:innen

antimicrobial activitybiocompatibilitybiofilm formationbone repairosteoblast differentiationplatelet-rich plasmascaffoldsilver

Substanzen

Silver

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Università del Piemonte Orientale "A. Avogadro", 28100 Novara, Italy.
  • Department of Industrial Engineering & BIOtech, University of Trento, 38123 Trento, Italy.

ORCID-Profile: Chiara Ceresa, Fabio Travagin, Alice Marchetti, Francesco Tessarolo, Letizia Fracchia, Giovanni Battista Giovenzana, Michela Bosetti

Förderung

  • Università del Piemonte Orientale Amedeo Avogadro
  • Università del Piemonte Orientale
  • European Union—Fondo Sociale Europeo Recovery Assistance for Cohesion
  • Territories of the European Union (FSE-REACT-EU), Programma Operativo Nazionale (PON), Azione IV.4

Zitieren

APA

Ceresa, C., Travagin, F., Marchetti, A., Tessarolo, F., Fracchia, L., Giovenzana, G. B., & Bosetti, M. (2024). An In Vitro Study on the Application of Silver-Doped Platelet-Rich Plasma in the Prevention of Post-Implant-Associated Infections. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094842

Vancouver

Ceresa C, Travagin F, Marchetti A, Tessarolo F, Fracchia L, Giovenzana GB, et al. An In Vitro Study on the Application of Silver-Doped Platelet-Rich Plasma in the Prevention of Post-Implant-Associated Infections. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094842

BibTeX
@article{Ceresa2024,
  author = {Ceresa, Chiara and Travagin, Fabio and Marchetti, Alice and Tessarolo, Francesco and Fracchia, Letizia and Giovenzana, Giovanni Battista and Bosetti, Michela},
  title = {An In Vitro Study on the Application of Silver-Doped Platelet-Rich Plasma in the Prevention of Post-Implant-Associated Infections},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094842}
}
Kostenlos starten →